Notice of Results & Investor Presentation

About this update from Ekf Diagnostics Holdings Plc

EKF Diagnostics Holdings plc ("EKF" or the "Company")   Notice of Interim Results & Investor Presentation   EKF Diagnostics Holdings plc  (AIM: EKF), the AIM-listed global diagnostics business, confirms that the Company will announce its interim results for the six months ended 30 June 2023 ("H1 2023"), on Tuesday 26 September 2023.   Investor Presentation Julian Baines, Executive Chair, and Steve Young, Chief Financial Officer, will be hosting a live online presentation relating to the interim results via the Investor Meet Company platform at 5.30 pm on Tuesday 26 September 2023. The presentation is open to all existing and potential investors.   Investors can sign up to Investor Meet Company for free and register for the presentation here:  https://www.investormeetcompany.com/ekf-diagnostics-holdings-plc/register-investor   Investors who already follow EKF on the Investor Meet Company platform will automatically be invited.   A recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards.     EKF Diagnostics Holdings plc www.ekfdiagnostics.com Julian Baines, Executive Chair  Tel: +44 (0)29 2071 0570 Singer Capital Markets (Nominated Adviser & Broker) Tel: +44 (0)20 7496 3000 Aubrey Powell / George Tzimas / Oliver Platts Walbrook PR Limited Tel: +44 (0)20 7933 8780 or [email protected] Paul McManus / Lianne Applegarth Mob: +44 (0)7980 541 893 / +44 (0)7584 391 303   About EKF Diagnostics Holdings plc ( www.ekfdiagnostics.com )   EKF is an AIM-listed global diagnostics business focussed on:   ·    Point-of-Care analysers in the key areas of Hematology and Diabetes, as well as Central Laboratory products including clinical chemistry reagents, analysers and centrifuges   ·    Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications, as well as other higher value Contract Manufacturing services   EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

View stock analysis, news, and events for Ekf Diagnostics Holdings Plc